A short lipidated peptide breaks an ion-channel partnership and quiets pain-signalling neurons in mouse models
Researchers at Boston Children's Hospital have reported in Cell Reports Medicine that the sodium channel NaV1.8, which helps pain-sensing neurons fire, depends on a scaffolding protein called ankyrin-G (Ank3) to sustain the heightened electrical activity seen in pathological pain.
Summary. Researchers at Boston Children's Hospital have reported in Cell Reports Medicine that the sodium channel NaV1.8, which helps pain-sensing neurons fire, depends on a scaffolding protein called ankyrin-G (Ank3) to sustain the heightened electrical activity seen in pathological pain. Earlier strategies against NaV1.8 aimed to stop the channel opening properly. This team instead used a short lipidated peptide (SLiP) designed to act as a "bait" for Ank3 and compete with the channel for binding. In mouse models, disrupting the interaction lowered NaV1.8 levels in the cell membrane, quietened hyperexcitable nociceptors and reduced pain-like behaviours, while acute protective pain responses were spared.
Research context (RUO). The study is preclinical: the findings come from mouse models and sensory neurons, not from people, and the press release itself notes that NaV inhibition strategies that worked preclinically have so far not produced similar results in clinical settings. The interest for laboratories is the mechanism. The work treats an ion channel as a protein whose presence in the membrane can be changed by targeting a partner protein, rather than only as a pore to block. The intellectual property has been licensed to a Boston biotechnology company developing investigational candidates, so independent replication of the interaction findings will be the next test.
